Stay updated on Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer’s site revision identifier was updated from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T23:29:25.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A general NIH notice about the website terminology transition appears above the ClinicalTrials.gov 403 error page. The site revision label also changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:15:05.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision identifier advances from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:15:14.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study content, presenting a generic error view with the site header and footer intact. This indicates access to the study record is blocked.
    Difference
    19%
    Check dated 2026-09-22T23:44:13.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.6 to v3.7.0, indicating a newer version of the page.
    Difference
    0.1%
    Check dated 2026-09-15T22:27:26.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, indicating a new release of the page. This update is a metadata change and does not pertain to the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-09-01T20:58:27.000Z thumbnail image

Stay in the know with updates to Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.